Industry Group CEO: “Data certainly does not support” FDA regulatory approach to vaping


Vaping Post’s Diane Caruana, our in-house wire journalist, recently wrote a briefing about the latest round of critique related to the U.S. Food and Drug Administration’s (

Previous articleAltria’s Smokeless Products Division Could Add $930 Million in Revenue
Next articleTax Proposal Could Devastate Ohio Vape Industry